Invention Grant
- Patent Title: Dimethyl 7-bromo-1-(4-substituted benzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylates as anti-inflammatory agents
-
Application No.: US18371126Application Date: 2023-09-21
-
Publication No.: US11945819B1Publication Date: 2024-04-02
- Inventor: Katharigatta N. Venugopala , Pran Kishore Deb , Pramod Patil , Osama I. Alwassil , Mohamed A. Morsy , Bandar Aldhubiab , Vijaykumar Uppar , Mahmoud Kandeel , Praveen B. Managutti , Basavaraj Padmashali
- Applicant: KING FAISAL UNIVERSITY
- Applicant Address: SA Al-Ahsa
- Assignee: KING FAISAL UNIVERSITY
- Current Assignee: KING FAISAL UNIVERSITY
- Current Assignee Address: SA Al-Ahsa
- Agency: Nath, Goldberg & Meyer
- Agent Richard C. Litman
- Main IPC: A61K31/4353
- IPC: A61K31/4353 ; A61P29/00 ; C07D471/04 ; C07D471/16
![Dimethyl 7-bromo-1-(4-substituted benzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylates as anti-inflammatory agents](/abs-image/US/2024/04/02/US11945819B1/abs.jpg.150x150.jpg)
Abstract:
Novel dimethyl 7-bromo-1-(4-substituted benzoyl)pyrrolo[1,2-α]quinoline-2,3-dicarboxylates compounds, having the structure:
A method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The dimethyl 7-bromo-1-(4-substituted benzoyl)pyrrolo[1,2-α]quinoline-2,3-dicarboxylates compounds, identified as anti-inflammatory agents, are useful for treating inflammation, pain, and swelling in a patient.
A method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The dimethyl 7-bromo-1-(4-substituted benzoyl)pyrrolo[1,2-α]quinoline-2,3-dicarboxylates compounds, identified as anti-inflammatory agents, are useful for treating inflammation, pain, and swelling in a patient.
Information query